ask="4.50"
ask_size="4000"
average_daily_volume="112177"
bid="3.84"
bid_size="100"
book_value="2.54"
change="-0.08"
change_from_200_day_moving_average="-1.23"
change_from_50_day_moving_average="-0.26"
change_from_52_week_high="-7.56"
change_From_52_week_low="0.27"
change_in_percent="-1.95%"
close="4.03"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.51"
ebitda="-74.76M"
eps_estimate_current_year="-1.08"
eps_estimate_next_quarter="-0.29"
eps_estimate_next_year="-1.20"
ex_dividend_date="N/A"
float_shares="24541000"
high="4.17"
high_52_weeks="11.59"
last_trade_date="2/28/2017"
last_trade_price="4.03"
last_trade_size="181"
last_trade_time="4:00pm"
low="4.01"
low_52_weeks="3.76"
market_capitalization="285.26M"
moving_average_200_day="5.26"
moving_average_50_day="4.29"
name="Adaptimmune Therapeutics plc"
notes="N/A"
one_year_target_price="14.83"
open="4.12"
pe_ratio="N/A"
peg_ratio="0.28"
percent_change_from_200_day_moving_average="-23.37%"
percent_change_from_50_day_moving_average="-5.98%"
percent_change_from_52_week_high="-65.22%"
percent_change_from_52_week_low="+7.18%"
previous_close="4.11"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.62"
price_per_sales="30.55"
revenue="9.52M"
shares_outstanding="70785000"
short_ratio="3.03"
stock_exchange="NMS"
symbol="ADAP"
volume="47393"
weeks_range_52="3.76 - 11.59"
